Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q2 2026

Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.

Institution overview
Positions
66
+4 vs. Q1 2026
Portfolio value
$6.79B
+$1.94B (+40.1%) vs. Q1 2026
Filed
Aug 14, 2026
SEC
Holdings of Deep Track Capital, LP in Q2 2026
SecurityClassSharesValue% of portfolioShare changeActionHistory
GHGuardant Health, Inc.COM3,393,312$509.1M7.5%+55,071+1.6%AddedHistory
IMVTImmunovant, Inc.COM9,341,151$359.9M5.3%−2,185,820−19.0%ReducedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS4,740,072$254.4M3.7%+460,224+10.8%AddedHistory
PCVXVaxcyte, Inc.COM4,300,000$250.0M3.7%00.0%UnchangedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM825,000$248.3M3.7%+825,000NewHistory
MANEVeradermics, IncCOMMON STOCK2,000,000$245.9M3.6%+1,500,000+300.0%AddedHistory
TARSTarsus Pharmaceuticals, Inc.COM3,666,768$230.8M3.4%+66,768+1.9%AddedHistory
NUVLNuvalent, Inc.COM1,783,322$220.2M3.2%+406,998+29.6%AddedHistory
ALKSAlkermes plc.SHS4,000,000$209.6M3.1%+409,677+11.4%AddedHistory
OCULOcular Therapeutix, IncCOM19,686,282$193.3M2.8%00.0%UnchangedHistory
BMRNBiomarin Pharmaceutical IncCOM3,307,481$189.3M2.8%+2,157,481+187.6%AddedHistory
NRIXNurix Therapeutics, Inc.COM7,736,455$187.7M2.8%+1,391,211+21.9%AddedHistory
ORKAOruka Therapeutics, Inc.COM1,926,000$183.3M2.7%−108,203−5.3%ReducedHistory
ALMSAlumis Inc.COM6,348,558$178.6M2.6%−424,037−6.3%ReducedHistory
IONSIonis Pharmaceuticals IncCOM2,200,000$174.4M2.6%+250,000+12.8%AddedHistory
CMPSCOMPASS Pathways plcSPONSORED ADS12,161,496$172.1M2.5%00.0%UnchangedHistory
VERAVera Therapeutics, Inc.CL A4,000,000$171.6M2.5%−106,067−2.6%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM700,000$171.3M2.5%−400,000−36.4%ReducedHistory
GMABGenmab A/SSPONSORED ADS5,650,000$155.2M2.3%+1,986,750+54.2%AddedHistory
MLTXMoonLake ImmunotherapeuticsCLASS A ORD6,999,025$136.3M2.0%+590,162+9.2%AddedHistory
COAGHemab Therapeutics Holdings, Inc.COM SHS3,602,093$132.3M1.9%+3,602,093NewHistory
TNGXTango Therapeutics, Inc.COM4,200,000$131.3M1.9%+1,450,000+52.7%AddedHistory
DFTXDefinium Therapeutics, Inc.COM SHS2,750,000$129.4M1.9%−250,000−8.3%ReducedHistory
GRALGRAIL, Inc.COM1,834,944$125.3M1.8%+112,147+6.5%AddedHistory
BCAXBicara Therapeutics Inc.COM4,100,000$121.7M1.8%+37,500+0.9%AddedHistory
MAZEMaze Therapeutics, Inc.COM3,732,569$111.4M1.6%+255,007+7.3%AddedHistory
CLDXCelldex Therapeutics, Inc.COM NEW2,939,151$109.4M1.6%+1,655,172+128.9%AddedHistory
LBRXLB Pharmaceuticals IncCOM SHS3,352,804$108.8M1.6%00.0%UnchangedHistory
MBXMBX Biosciences, Inc.COM1,732,569$95.6M1.4%−1,025,000−37.2%ReducedHistory
GHRSGH Research PLCORDINARY SHARES3,333,334$89.6M1.3%+3,333,334NewHistory
COGTCogent Biosciences, Inc.COM2,000,000$77.4M1.1%+1,000,000+100.0%AddedHistory
ATAIAtaiBeckley Inc.COM SHS14,417,442$76.0M1.1%+2,417,442+20.1%AddedHistory
UTHRUnited Therapeutics CorpCOM123,616$67.0M1.0%+123,616NewHistory
AVTXAvalo Therapeutics, Inc.COM NEW3,610,000$66.7M1.0%+3,610,000NewHistory
VRDNViridian Therapeutics, Inc.COM3,592,740$66.0M1.0%+2,198,796+157.7%AddedHistory
CYTKCytokinetics IncCOM NEW700,000$59.6M0.9%−674,320−49.1%ReducedHistory
ALTAltimmune, Inc.COM NEW19,250,000$58.5M0.9%+19,250,000NewHistory
PSNLPersonalis, Inc.COM4,000,000$53.6M0.8%+1,000,000+33.3%AddedHistory
ACRSAclaris Therapeutics, Inc.COM9,345,000$49.4M0.7%00.0%UnchangedHistory
CRMDCorMedix Inc.COM6,274,076$49.3M0.7%00.0%UnchangedHistory
WGSGeneDx Holdings Corp.COM CL A700,000$48.1M0.7%+700,000NewHistory
HROWHarrow, Inc.COM969,000$41.2M0.6%+969,000NewHistory
CRVSCorvus Pharmaceuticals, Inc.COM2,491,939$37.2M0.5%+4000.0%AddedHistory
SLDBSolid Biosciences Inc.COM NEW3,565,062$35.6M0.5%00.0%UnchangedHistory
BEAMBeam Therapeutics Inc.COM1,000,000$34.3M0.5%+179,235+21.8%AddedHistory
DYNDyne Therapeutics, Inc.COM1,500,000$33.3M0.5%−500,000−25.0%ReducedHistory
IMMXImmix Biopharma, Inc.COM2,775,000$28.6M0.4%+2,775,000NewHistory
XFORX4 Pharmaceuticals, IncCOM NEW5,878,757$27.5M0.4%−460,778−7.3%ReducedHistory
STTKShattuck Labs, Inc.COM3,706,734$25.7M0.4%+3,706,734NewHistory
MNKDMannkind CorpCOM NEW6,000,000$25.6M0.4%+6,000,000NewHistory
IPSCCentury Therapeutics, Inc.COM9,462,645$23.2M0.3%−25,100−0.3%ReducedHistory
GENBGenerate Biomedicines, Inc.COM SHS1,333,815$22.5M0.3%+1,333,815NewHistory
VSTMVerastem, Inc.COM NEW5,740,850$21.9M0.3%00.0%UnchangedHistory
KURAKura Oncology, Inc.COM1,978,565$21.7M0.3%−664,977−25.2%ReducedHistory
ENTAEnanta Pharmaceuticals IncCOM1,444,167$21.1M0.3%−512,700−26.2%ReducedHistory
NKTRNektar TherapeuticsCOM NEW300,000$20.9M0.3%+300,000NewHistory
OLMAOlema Pharmaceuticals, Inc.COM1,500,000$18.8M0.3%+1,500,000NewHistory
KLRAKailera Therapeutics, Inc.COMMON STOCK700,000$15.4M0.2%+700,000NewHistory
KARDKardigan, Inc.COM600,000$14.3M0.2%+600,000NewHistory
ELVNEnliven Therapeutics, Inc.COM225,000$11.4M0.2%+225,000NewHistory
PMNProMIS Neurosciences Inc.COM SHS835,655$11.0M0.2%00.0%UnchangedHistory
IMCRImmunocore Holdings plcADS311,218$9.88M0.1%−1,620,666−83.9%ReducedHistory
XNCRXencor IncCOM593,551$9.56M0.1%+593,551NewHistory
CNTXContext Therapeutics Inc.COM7,419,355$4.11M0.1%00.0%UnchangedHistory
IVAInventiva S.A.ADS800,000$3.02M<0.1%−422,453−34.6%ReducedHistory
ALGSAligos Therapeutics, Inc.COM NEW444,110$2.56M<0.1%00.0%UnchangedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q2 2026
SecurityClassPutsCalls
GMABGenmab A/SSPONSORED ADS–$82.4M

Sold out since Q1 2026 (14)

Positions held at the end of Q1 2026 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q1 2026
SecurityClassShares in Q1 2026Value in Q1 2026% of portfolio in Q1 2026History
APLSApellis Pharmaceuticals, Inc.COM4,532,374$182.3M3.8%History
CNTACentessa Pharmaceuticals plcSPONSORED ADS3,158,041$125.4M2.6%History
BBIOBridgeBio Pharma, Inc.COM841,445$62.5M1.3%History
TERNTerns Pharmaceuticals, Inc.COM1,073,877$56.6M1.2%History
GERNGeron CorpCOM31,720,278$47.3M1.0%History
ANIPAni Pharmaceuticals IncCOM600,000$46.1M1.0%History
SLNOSoleno Therapeutics IncCOM1,078,710$36.1M0.7%History
ENGNenGene Therapeutics Inc.COM4,377,572$29.8M0.6%History
APGEApogee Therapeutics, Inc.COM285,000$24.0M0.5%History
JANXJanux Therapeutics, Inc.COM1,187,290$16.5M0.3%History
CBIOCrescent Biopharma, Inc.COM453,686$8.33M0.2%History
LRMRLarimar Therapeutics, Inc.COM1,500,000$6.75M0.1%History
HELPCybin Inc.COM NEW1,313,137$6.30M0.1%History
BLLNBillionToOne, Inc.CL A50,000$3.95M0.1%History